title: Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines.
authors.affiliation: Department of Medicine, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. moshemt@tasmc.health.gov.il
authors.forename: Moshe
authors.initials: M
authors.lastname: Mittelman
authors.forename: Gilles
authors.initials: G
authors.lastname: Lugassy
authors.forename: Drorit
authors.initials: D
authors.lastname: Merkel
authors.forename: Hannah
authors.initials: H
authors.lastname: Tamary
authors.forename: Nadav
authors.initials: N
authors.lastname: Sarid
authors.forename: Eliezer
authors.initials: E
authors.lastname: Rachmilewitz
authors.forename: Chaim
authors.initials: C
authors.lastname: Hershko
mesh_terms: D000740:Anemia / Q000209:etiology / Q000628:therapy; D005293:Ferritins / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000150:complications*; D018579:Patient Selection; D065227:Transfusion Reaction
chemical_list: D007502:Iron Chelating Agents; D005293:Ferritins; D007501:Iron